Home/Oxurion/James Hartmann

JH

James Hartmann

Independent Non-Executive Director

Therapeutic Areas

Ophthalmology Retinal Diseases

Oxurion Pipeline

Drug	Indication	Phase
Undisclosed Next-Gen Therapies	Geographic Atrophy (GA) / Age-related Macular Degeneration (AMD)	Unspecified

Leadership Team at Oxurion

Charles Paris de Bollardière

Chairman Of The Board

Nelly Souleymane

Independent Non-Executive Director

View full Oxurion profile